Good quareterly growth figures, funding the capital expansion out of cashflow.Product range expanding, the whole Woolworhts lable thing, which some see as risky, I see as a positive.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025